In this report, we describe a proband with HLHS who developed significant aortic aneurysm in whom clinical sequencing for genetic causes of TAAD revealed a pathogenic mutation in SMAD3. Testing of the proband's family members lead to identification of a serious health risk for thus far two additional family members. This evidence concerns the gene SMAD3 and hypoplastic left heart syndrome.